Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Bank of America Analyst Says

Tempus AI (NASDAQ:TEM) had its target price raised by stock analysts at Bank of America from $52.00 to $54.00 in a research report issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Bank of America‘s price objective would indicate a potential upside of 26.52% from the stock’s current price.

Several other research firms also recently issued reports on TEM. Wolfe Research assumed coverage on shares of Tempus AI in a report on Friday. They set an “outperform” rating and a $60.00 price objective on the stock. Guggenheim began coverage on shares of Tempus AI in a research report on Monday. They set a “buy” rating and a $74.00 price target for the company. Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Piper Sandler restated a “neutral” rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Tempus AI Trading Up 1.6 %

Shares of NASDAQ:TEM traded up $0.69 during midday trading on Friday, reaching $42.68. 2,199,738 shares of the company’s stock traded hands, compared to its average volume of 1,404,566. The company has a fifty day simple moving average of $52.88. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insider Activity at Tempus AI

In other news, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of TEM. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the third quarter valued at about $30,000. Sandia Investment Management LP acquired a new stake in shares of Tempus AI during the second quarter valued at $136,000. Vestor Capital LLC purchased a new stake in Tempus AI during the 3rd quarter worth about $153,000. Stifel Financial Corp acquired a new position in Tempus AI in the 3rd quarter valued at about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI in the 3rd quarter valued at about $258,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.